Inventor · disambiguated record
Lauren Maceachern
Also filed as: MACEACHERN LAUREN · MACEACHERN LAUREN ASHLEY
5 granted patents·7 pending applications·1 citations·filing 2020–2024
64Inventor score
Files withGILGAMESH PHARMACEUTICALS INC5BLUEPRINT MEDICINES CORP4CRINETICS PHARMACEUTICALS INC1NUVALENT INC1RIGEL PHARMACEUTICALS INC1
Top patents by PatentIndex Score
12 records- 0180US11773076B2Crystalline forms of a somatostatin modulatorCRINETICS PHARMACEUTICALS INC·Filed 2022·Granted Oct 3, 2023·1 cites·29 claims
- 0279US12180158B1Crystalline fumarate salts of n-ethyl-2-(5-fluoro-1H-indol-3-yl)-n-methylethan-1-amineGILGAMESH PHARMACEUTICALS INC·Filed 2023·Granted Dec 31, 2024·0 cites·30 claims
- 0379US12157722B1Crystalline hydrochloride salts of N-ethyl-2-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amineGILGAMESH PHARMACEUTICALS INC·Filed 2023·Granted Dec 3, 2024·0 cites·10 claims
- 0476US2025115552A1Crystalline hydrochloride salts of n-ethyl-2-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amineGILGAMESH PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0569US12129234B1Crystalline salts of N-ethyl-(5-fluoro-1H-indol-3-yl)-N-methylethan-1-amineGILGAMESH PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·30 claims
- 0664US2025042851A1Crystalline salts of n-ethyl-(5-fluoro-1h-indol-3-yl)-n-methylethan-1-amineGILGAMESH PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0756US2024300922A1Process for preparing egfr inhibitorsBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 0854US12448366B2Solid forms of pralsetinibRIGEL PHARMACEUTICALS INC·Filed 2021·Granted Oct 21, 2025·0 cites·19 claims
- 0954US2024254130A1Salt and solid forms of a kinase inhibitorBLUEPRINT MEDICINES CORP·Filed 2022·Application pending·0 cites
- 1050US2023322797A1Solid forms, pharmaceutical compositions and preparation of heteroaromatic macrocyclic ether compoundsNUVALENT INC·Filed 2023·Application pending·0 cites
- 1150US2023203009A1Pralsetinib pharmaceutical compositionsBLUEPRINT MEDICINES CORP·Filed 2021·Application pending·0 cites
- 1247US2022281879A1Salt and crystal forms of an activin receptor-like kinase inhibitorBLUEPRINT MEDICINES CORP·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Lauren Maceachern files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →